Compounds > cidofovir anhydrous
Page last updated: 2024-08-24

cidofovir anhydrous and B16 Melanoma

cidofovir anhydrous has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gijsbers, S; Liekens, S; Noppen, S; Presta, M; Ronca, R; Sienaert, R; Tobia, C1
Galofré, JC; Idoate, M; Redondo, P; Solano, T1

Other Studies

2 other study(ies) available for cidofovir anhydrous and B16 Melanoma

ArticleYear
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.
    Oncotarget, 2015, Mar-10, Volume: 6, Issue:7

    Topics: Animals; Antiviral Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cidofovir; Cytosine; Embryo, Nonmammalian; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Fibroblasts; Humans; Immunoenzyme Techniques; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, SCID; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zebrafish

2015
Cidofovir inhibits growth of B16 melanoma cells in vivo.
    The British journal of dermatology, 2000, Volume: 143, Issue:4

    Topics: Animals; Antineoplastic Agents; Body Weight; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Organophosphonates; Organophosphorus Compounds; Skin Neoplasms

2000